Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
Antimicrobial Agents and Chemotherapy
|
August 24, 2011
Carbapenems: past, present, and future
Krisztina M Papp-Wallace, Andrea Endimiani, Magdalena A Taracila, et al.
Antimicrobial Agents and Chemotherapy
|
February 11, 2015
Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam
Krisztina M Papp-Wallace, Marisa L Winkler, Magdalena A Taracila, et al.
Chemmedchem
|
May 28, 2020
α-Triazolylboronic Acids: A Promising Scaffold for Effective Inhibitors of KPCs
Maria Luisa Introvigne, Magdalena A Taracila, Fabio Prati, et al.
Infectious Disease Clinics of North America
|
October 4, 2020
Resistance to Novel β-Lactam-β-Lactamase Inhibitor Combinations: The "Price of Progress"
Krisztina M Papp-Wallace, Andrew R Mack, Magdalena A Taracila, et al.
Antimicrobial Agents and Chemotherapy
|
February 19, 2015
Avibactam and inhibitor-resistant SHV β-lactamases
Marisa L Winkler, Krisztina M Papp-Wallace, Magdalena A Taracila, et al.
Journal of Medicinal Chemistry
|
June 24, 2015
Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors
Emilia Caselli, Chiara Romagnoli, Roza Vahabi, et al.
Antimicrobial Agents and Chemotherapy
|
August 22, 2012
Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance
Mei Li, Benjamin C Conklin, Magdalena A Taracila, et al.
Antimicrobial Agents and Chemotherapy
|
January 16, 2013
N152G, -S, and -T substitutions in CMY-2 β-lactamase increase catalytic efficiency for cefoxitin and inactivation rates for tazobactam
Marion J Skalweit, Mei Li, Benjamin C Conklin, et al.
Protein Science : a Publication of the Protein Society
|
December 21, 2016
Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase
Josephine P Werner, Joshua M Mitchell, Magdalena A Taracila, et al.
Antimicrobial Agents and Chemotherapy
|
June 13, 2012
Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276
Krisztina M Papp-Wallace, Magdalena A Taracila, Kerri M Smith, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
Antimicrobial Agents and Chemotherapy
|
August 24, 2011
Carbapenems: past, present, and future
Krisztina M Papp-Wallace, Andrea Endimiani, Magdalena A Taracila, et al.
Antimicrobial Agents and Chemotherapy
|
February 11, 2015
Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam
Krisztina M Papp-Wallace, Marisa L Winkler, Magdalena A Taracila, et al.
Chemmedchem
|
May 28, 2020
α-Triazolylboronic Acids: A Promising Scaffold for Effective Inhibitors of KPCs
Maria Luisa Introvigne, Magdalena A Taracila, Fabio Prati, et al.
Infectious Disease Clinics of North America
|
October 4, 2020
Resistance to Novel β-Lactam-β-Lactamase Inhibitor Combinations: The "Price of Progress"
Krisztina M Papp-Wallace, Andrew R Mack, Magdalena A Taracila, et al.
Antimicrobial Agents and Chemotherapy
|
February 19, 2015
Avibactam and inhibitor-resistant SHV β-lactamases
Marisa L Winkler, Krisztina M Papp-Wallace, Magdalena A Taracila, et al.
Journal of Medicinal Chemistry
|
June 24, 2015
Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors
Emilia Caselli, Chiara Romagnoli, Roza Vahabi, et al.
Antimicrobial Agents and Chemotherapy
|
August 22, 2012
Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance
Mei Li, Benjamin C Conklin, Magdalena A Taracila, et al.
Antimicrobial Agents and Chemotherapy
|
January 16, 2013
N152G, -S, and -T substitutions in CMY-2 β-lactamase increase catalytic efficiency for cefoxitin and inactivation rates for tazobactam
Marion J Skalweit, Mei Li, Benjamin C Conklin, et al.
Protein Science : a Publication of the Protein Society
|
December 21, 2016
Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase
Josephine P Werner, Joshua M Mitchell, Magdalena A Taracila, et al.
Antimicrobial Agents and Chemotherapy
|
June 13, 2012
Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276
Krisztina M Papp-Wallace, Magdalena A Taracila, Kerri M Smith, et al.
Page
of 7